Nanomedicine has advanced through increasingly sophisticated particle design, yet generalizable rules for productive delivery remain scarce. This gap persists in part because the receiving cell is still treated as assay background rather than as an active design variable. Bringing cell state into the design space can help to translate context-dependent performance into more actionable and predictive rules for nanomedicine development.
- Wenhan Wang
- Weijiang Yu
- Zongjie Wang